The DOI matches its Crossref record; 222 of the 225 references it cites were found in a registry or an index.
Assessment and treatment of depression in the cancer patient
Abstract
The prevalence, diagnosis, and treatment of depression in the cancer patient are reviewed. Although frequently encountered in the cancer patient population, depression often remains undiagnosed and untreated. This carries grave consequences in that depressed cancer patients experience a poorer quality of life, are less compliant with medical care, have longer hospital stays, and have higher mortality rates. Diagnostic assessment of depression in the cancer patient raises difficulties both upon phenomenological and etiological grounds. In particular, the presence of neurovegetative symptoms which may be secondary to either cancer or depression may cloud the diagnostic picture. Due to the serious consequences of unrecognized depression, a more sensitive inclusive approach to diagnosis is recommended in the clinical setting. Finally, the limited data regarding treatment of depression in patients with cancer is reviewed. This includes a discussion of both psychosocial and pharmacological interventions which are shown to alleviate depression, improve quality of life measures, improve immune function, and lengthen survival time.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Despite the fact that many patients suffer from high distress, identification of those is often insufficient in clinical oncology settings and the rate of referral to mental health professionals is low [12,13].”
From Development of a screening tool for the identification of psychooncological treatment need in breast cancer patients (2009) · cites this paper as [13]
Citations
Cites
Cancer: Principles and Practice of Oncology.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-819_4 · Cited by 8,516
Kübler-Ross, E. (1975) · PubMed · Cited by 4,935
THE CATECHOLAMINE HYPOTHESIS OF AFFECTIVE DISORDERS: A REVIEW OF SUPPORTING EVIDENCE
SCHILDKRAUT, J. J. (1965) · American Journal of Psychiatry · doi:10.1176/ajp.122.5.509 · Cited by 3,492
EFFECT OF PSYCHOSOCIAL TREATMENT ON SURVIVAL OF PATIENTS WITH METASTATIC BREAST CANCER
Spiegel, D., Kraemer, H., Bloom, J., & Gottheil, E. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91551-1 · Cited by 2,353
Nemeroff, C. B., Widerlöv, E., Bissette, G., Walléus, H., Karlsson, I., Eklund, K., Kilts, C. D., Loosen, P. T., & Vale, W. (1984) · Science · doi:10.1126/science.6334362 · Cited by 1,485
Self-citationEvidence for an immune response in major depression: A review and hypothesis
Maes, M. (1995) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(94)00101-m · Cited by 1,003
The principles and practice of oncology
Johnston, P. G., & McDermott, U. (2001) · Oncology · doi:10.1093/oso/9780192629821.003.0001 · Cited by 961
Group Support for Patients With Metastatic Cancer: A Randomized Prospective Outcome Study
Spiegel, D. (1981) · Archives of General Psychiatry · doi:10.1001/archpsyc.1980.01780300039004 · Cited by 862
Depression and immunity: A meta-analytic review.
Herbert, T. B., & Cohen, S. (1993) · Psychological Bulletin · doi:10.1037/0033-2909.113.3.472 · Cited by 803
Gold, P. W., Loriaux, D. L., Roy, A., Kling, M. A., Calabrese, J. R., Kellner, C. H., Nieman, L. K., Post, R. M., Pickar, D., Gallucci, W., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198605223142101 · Cited by 766
Research works printed but not linked: 13
- Feldman, 1987, Psychiatric disorders in medical inpatients, Q J Med, 144, 931
- Holland, 1974, Psychiatric symptoms associated with l-asparaginase, J Psychiatric Res, 10, 165
- Poisner, 1971, A possible role of microtubules in catecholamine release from the adrenal medulla, J Pharmacol Exp Ther, 177, 102
- Omne-Ponten, 1992, Determinants of the psychosocial outcome after operation for breast cancer, Eur J Cancer, 28, 1062
- Ulrich, 1967, Neurologische syndrome als fernwirkung maligner tumoren, Schweiz Arch Neurol Neurochir Psychiatrica, 99, 83
- Clayton, 1990, Course of depressive symptoms following the course of bereavement, J Clin Psychiatry, 51, 34
- Diagnostic and statistical manual of mental disorders, 4th ed. Washington, DC: American Psychiatric Press 1994.
- Schatzberg, 1984, The DST in psychotic depression, Psychopharmacol Bull, 20, 362
- Stein M, Miller A. Brain, behavior, and immune system: foreword. In: Tasman A, Riba M, eds. American Psychiatric Press review of psychiatry. Volume II. Washington, DC: American Psychiatric Press 1992:123–126.
- Blalock, 1984, Relationships between neuroendocrine hormones and lymphokines, Lymphokines, 9, 1
- Natenshon, 1956, Clinical evaluation of Ritalin, Dis Nerv Syst, 17, 392
- Nemeroff, 1996, The corticotropin-releasing factor (CRF) hypothesis of depression, Molec Psychiatry, 1, 336
- Grandi, 1987, Major depression associated with mastectomy, Med Sci Res, 15, 283
Cited by
Prevalence of depression in patients with cancer
Massie, M. J. (2004) · Journal of the National Cancer Institute Monographs · doi:10.1093/jncimonographs/lgh014 · Cited by 1,408
Mood disorders in the medically ill: scientific review and recommendations
Evans, D. L., Charney, D. S., Lewis, L., Golden, R. N., Gorman, J. M., Krishnan, K. R. R., Nemeroff, C. B., Bremner, J. D., Carney, R. M., Coyne, J. C., et al. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.05.001 · Cited by 1,071
Self-citationKrebber, A. M. H., Buffart, L. M., Kleijn, G., Riepma, I. C., de Bree, R., Leemans, C. R., Becker, A., Brug, J., van Straten, A., Cuijpers, P., et al. (2014) · Psycho-Oncology · doi:10.1002/pon.3409 · Cited by 908
Depression and cancer: mechanisms and disease progression
Spiegel, D., & Giese-Davis, J. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00566-3 · Cited by 874
“Depression in patients with cancer has been underdiagnosed and undertreated due, in part, to the belief that depression is a normal and universal reaction to serious disease (Newport and Nemeroff 1998; Rodin and Voshart 1986; Spiegel 1996) and, in part, because the neurovegetative signs (weight loss, sleep disturbance…”
BackgroundJacobsen, P. B., & Jim, H. S. (2008) · CA: A Cancer Journal for Clinicians · doi:10.3322/ca.2008.0003 · Cited by 382
Metadata
- Authors
- Newport, D. J., & Nemeroff, C. B.
- Affiliations
- Emory University (US)
- Corresponding author
- Nemeroff, Charles B.
- Venue
- Journal of Psychosomatic Research
- Publisher
- Elsevier BV
- Published
- 1998-09
- Volume
- 45
- Issue
- 3
- Pages
- 215-237
- ISSN
- 0022-3999 (ISSN-L)
- OpenAlex
- W2141217260
- Cited by
- 167
- References
- 225
- Citations by year
- 2025: 2 · 2024: 1 · 2023: 1 · 2022: 3 · 2021: 4 · 2020: 5 · 2019: 3 · 2018: 4 · 2017: 4 · 2016: 7 · 2015: 5 · 2014: 5 · 2013: 8 · 2012: 15
- FWCI
- 0.31
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Journal of Psychosomatic Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer survivorship and care
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Keywords
- depression, cancer patients, depression diagnosis, depression treatment, quality of life, medication adherence, neurovegetative symptoms, psychosocial interventions, pharmacotherapy, immune function, survival
- MeSH terms
- Adrenocorticotropic Hormone, Bereavement, Corticotropin-Releasing Hormone, Depressive Disorder, Female, Health Status, Humans, Hypothalamo-Hypophyseal System, Killer Cells, Natural, Male, Neoplasms, Pituitary-Adrenal System, Psychotherapy, Quality of Life, Stress, Psychological
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Assessment and treatment of depression in the cancer patient. https://app.cochat.ai/papers/10.1016/s0022-3999(98)00011-7
- The paper
- Newport, D. J., & Nemeroff, C. B. (1998). Assessment and treatment of depression in the cancer patient. Journal of Psychosomatic Research. https://doi.org/10.1016/s0022-3999(98)00011-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.